On April 16 2018, Canon Medical Systems Europe (CMSE) B.V. has signed a reseller agreement with the Swedish medical device company Arcoma, allowing Canon Medical Systems to sell the high-end digital x-ray systems ‘Aceso’ and ‘Aceso+’ in Europe.
Arcoma and Canon Medical Systems already had a strong partnership in place, enabling Arcoma to deliver completely integrated systems to its clients using Canon’s imaging software and detectors. The reseller agreement marks a new step in the partnership.
“We were looking to strengthen our product portfolio in the diagnostic x-ray segment. The market is requesting robust and high-end auto-positioning systems," said René Degros, European sales director at CMSE. "With the Aceso and Aceso+ we will definitely integrate very reliable clinical solutions in our portfolio, allowing our customers to improve their workflow and patient outcome.”
Aceso and Aceso+
Both Aceso and Aceso+ are high-end Arcoma solutions powered by Canon Medical Systems imaging technology.
The Aceso DR System is a high quality, yet cost-effective DR imaging solution. Featuring a variety of imaging platforms, including a new line up of high-end flat panel detectors, the Aceso provides a solution to a wide variety of clinical needs, featuring Arcoma’s Smart Space concept the system can be installed in both the tallest and shortest of rooms.
The Aceso+ represents the optimum combination of the 4th generation auto-positioning technology with ergonomic design, resulting in a digital radiographic system that creates an efficient workflow and maximizes patient throughput. Featuring advanced applications like auto-stitching and auto detector tracking of both table and vertical stand, Aceso+ is suitable for the most diverse imaging needs.
“We are very pleased to extend our collaboration with Canon Medical Systems. Canon’s choice to include Arcoma systems in their portfolio is really encouraging. It is an acknowledgement of our technology and very reliable products. With this agreement Arcoma gets a significantly improved market presence in central and southern Europe. In northern Europe where Arcoma and Canon already have strong and very competent business partners, this collaboration further improves presence and enables participation in multimodality deals that require a wider product portfolio,” said Arcoma CEO Jesper Söderqvist.
Notes to the editor:
For more information, please contact Serge Beckers at Wisse Kommunikatie, via +31 26 4431523 or via email@example.com.
- Shayan Khan – e-Marketing & PR manager, Canon Medical Systems Europe
(firstname.lastname@example.org | +31 622 78 70 50)
- Jack J.F. Hoogendoorn – Senior Manager Marketing, Canon Medical Systems Europe
(email@example.com | +31 6 51 86 11 92)
- Joerg Schlegel – Senior Product Marketing Manager, Canon Medical Systems
(Joerg.Schlegel@eu.medical.canon | +31 6 43 07 33 42)
About Canon Medical Systems Corporation
Canon Medical Systems offers a full range of diagnostic medical imaging solutions including CT, MR, ultrasound, diagnostic and interventional x-ray equipment and advanced software that enables visualization and analysis of 2D, 3D, and 4D images of anatomy and physiological functions across the globe. Under the slogan “Made for Life” (Made for Partnerships, Made for Patients, Made for You), Canon Medical Systems is making positive contributions toward hospital management, and provides a range of patient-friendly healthcare systems and services, continuing its long tradition of contributing to healthcare.
Arcoma, with long experience in the industry, is a leading provider of integrated digital X-ray systems with high quality and advanced technology. Arcoma’s products offer the latest digital imaging technology combined with technically advanced moving positioning systems and ergonomic Scandinavian design. Arcoma offers the customers complete, configurable and functional digital x-ray systems. The company’s products are sold through retailers as well as OEM customers and today there are over 3,500 of Arcoma’s x-ray systems installed worldwide. Arcoma is listed on Nasdaq First North.